Pharmaceuticals
10 formulation development experts
These ten professionals have led formulation development in their own roles at pharmaceutical and biotech companies. A reader can learn how drug developers plan formulation and drug product work across the stages of development.
Professionals to explore
01—10Anthony S. Ham
LinkedInExperience: Senior Director, Formulation Development · Novavax
Senior Director, Formulation Development at Novavax since 2022 and former Director, Formulation Development there (2020–2022). The profile says this person leads a multi-disciplinary R&D group of researchers and engineers with expertise in formulation, bioengineering, pharmaceutics and product development; it also lists Director, Formulation at Prometic (2017–2020).
Brahma N. Singh
LinkedInExperience: Sr. Director, Formulation Development · Acadia Pharmaceuticals
Sr. Director, Formulation Development at Acadia Pharmaceuticals since 2024 and former Director, Formulation Development there (2019–2024). The profile describes about 25 years advancing small-molecule portfolios from early development through regulatory approval, commercialization and lifecycle management; it also lists Director, Product Development, Generics R&D (Teva) at Teva Pharmaceuticals (2016–2017).
Christopher Mensch
LinkedInExperience: AVP, Head of Drug Product Formulation Development & Analytical Development · Kalaris Therapeutics
AVP, Head of Drug Product Formulation Development & Analytical Development at Kalaris Therapeutics since 2025. Former Senior Director of Drug Product Research, Development , Manufacturing, and Supply (2024–2025) and Director of Drug Product Development (2022–2023) at IGM Biosciences, Inc.; the profile mentions work on therapeutic proteins, lyophilized, liquid and high concentration presentations, stability, and route of delivery and device selection.
Hulya Sahin, Ph.D.
LinkedInExperience: Director, Formulation · Cogent Biosciences
Director, Formulation at Cogent Biosciences since 2021. Former Director, Technical Services at Cosette Pharmaceuticals, Inc. (2019–2020) and Director Product Development at UPM Pharmaceuticals (2014–2018); the profile describes expertise in pre-formulation, formulation development, scale up, technology transfer and process validation and qualification.
Jaidev S. Tantry
LinkedInExperience: Director, Formulation Development · Acadia Pharmaceuticals
Director, Formulation Development at Acadia Pharmaceuticals since 2023, where the profile says the role manages formulation, primary package and manufacturing process development for the company's assets at all stages of development and across dosage forms. Former Director, Formulation Development and Manufacture at Aptinyx Inc. (2019–2023) and Associate Director, Pharmaceutical Development at Upsher-Smith (2016–2019).
Jason D Legassie
LinkedInExperience: Senior Director, Head of Formulation Development · Sage Therapeutics
Former Senior Director, Head of Formulation Development (2024–2025) and Director, Formulation Development (2021–2024) at Sage Therapeutics, and Executive Director, Drug Product CMC at Xenon Pharmaceuticals Inc. since 2025. The profile describes developing prescription drugs (NDA and ANDA) and OTC drugs, with experience in topical and solid dosage forms.
Jeffrey Hemenway
LinkedInExperience: Senior Director, Formulation and Process Development · Gilead Sciences
Senior Director, Formulation and Process Development at Gilead Sciences since 2023 and former Director, Formulation and Process Development there (2019–2023). The profile describes this person as a scientific group leader in Formulation and Process Development working on products through all stages from discovery through commercialization; it also lists Senior Research Scientist I II, Formulation and Process Development at Gilead Sciences (2014–2019).
Richard Hu
LinkedInExperience: Senior Director of Formulation Development · EyePoint
Senior Director of Formulation Development at EyePoint since 2024 and former Director of Formulation Development there (2021–2024). The profile mentions managing formulation research and managing contract manufacturing and contract research organizations; it also lists Director of CMC at Arsenal Medical (2020–2021) and Associate Director at Curis (2015–2020).
Srinivasa Murthy Sammeta
LinkedInExperience: Director - Formulation Development · Teva Pharmaceuticals
Director - Formulation Development at Teva Pharmaceuticals since 2021, a role in which the profile says this person led a team of formulation scientists developing complex drug products across therapeutic areas and dosage forms. Former Associate Director Product Development at Teva Pharmaceuticals (2018–2021) and Principal Scientist - Formulation at Actavis (Teva Pharmaceuticals) (2015–2018).
Vishal Toprani
LinkedInExperience: Director, Formulation and Drug Product Development · Upstream Bio
Director, Formulation and Drug Product Development at Upstream Bio since 2024. Former Principal Scientist (2021–2024) and Senior Scientist, Biotherapeutics and Pharmaceutical Sciences (2019–2021) at Pfizer; the profile describes early and late-stage drug product development through commercialization, with a focus on biologics and PFS combination products.
Choose the right perspective
Match the person's modality and dosage forms to yours, since oral solids, injectables and biologic drug products raise different formulation problems. Also consider whether you need help with an early clinical formulation or with scale-up and transfer to a commercial manufacturer, and ask which of these the person has handled directly.
Questions to take into the conversation
- 01How do you choose a formulation for a first clinical trial without boxing in the commercial product?
- 02What usually goes wrong when a formulation is scaled up or moved to a contract manufacturer, and how do you prevent it?
- 03How do you decide when a formulation change mid-development is worth the extra bridging work?
Reaching formulation development experts
How can I contact one of these formulation development experts?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 9 companies, including Novavax, Acadia Pharmaceuticals and Kalaris Therapeutics, based on profile data retrieved on October 4, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach formulation development experts?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal